IgE-directed Antibody Interactions [MoA] - N0000175792

Pharmacologic Code	N0000175792
Pharmacologic Name	IgE-directed Antibody Interactions
Pharmacologic Uses	anti-IgE
Pharmacologic Concept	Mechanisms of Action - [MoA]
Pharmacologic Concept Description	This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

The table contains 7 products whose active ingredient are classified under the same pharmacologic class IgE-directed Antibody Interactions [MoA].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	50242-040	Xolair	Non-Proprietary Name: Omalizumab	Injection, Solution	Subcutaneous	Genentech, Inc.	ACTIVE
	50242-214	Xolair Pfs	Non-Proprietary Name: Omalizumab	Injection, Solution	Subcutaneous	Genentech, Inc.	ACTIVE
	50242-215	Xolair Pfs	Non-Proprietary Name: Omalizumab	Injection, Solution	Subcutaneous	Genentech, Inc.	ACTIVE
	50242-227	Xolair	Non-Proprietary Name: Omalizumab	Injection, Solution	Subcutaneous	Genentech, Inc.	ACTIVE
	72606-035	Omlyclo	Non-Proprietary Name: Omalizumab-igec	Injection	Subcutaneous	Celltrion Usa, Inc.	ACTIVE
	72606-036	Omlyclo	Non-Proprietary Name: Omalizumab-igec	Injection	Subcutaneous	Celltrion Usa, Inc.	ACTIVE
	72606-054	Omlyclo	Non-Proprietary Name: Omalizumab-igec	Injection	Subcutaneous	Celltrion Usa, Inc.	ACTIVE